These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Labrie F; Bélanger A; Cusan L; Candas B J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308 [TBL] [Abstract][Full Text] [Related]
27. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels. Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633 [TBL] [Abstract][Full Text] [Related]
28. Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women. Meikle AW; Odell WD Fertil Steril; 1986 Aug; 46(2):227-31. PubMed ID: 3015694 [TBL] [Abstract][Full Text] [Related]
29. Elevated production and metabolic clearance rates of androgens in morbidly obese women. Samojlik E; Kirschner MA; Silber D; Schneider G; Ertel NH J Clin Endocrinol Metab; 1984 Nov; 59(5):949-54. PubMed ID: 6480813 [TBL] [Abstract][Full Text] [Related]
30. New therapeutic approach to the hirsute patient. Boisselle A; Tremblay RR Fertil Steril; 1979 Sep; 32(3):276-9. PubMed ID: 488407 [TBL] [Abstract][Full Text] [Related]
32. Predictors of clinical response in hirsute women treated with spironolactone. Crosby PD; Rittmaster RS Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043 [TBL] [Abstract][Full Text] [Related]
33. [Determination of plasma 5 alpha-androstane-3 alpha, 17 beta-diol in the hirsute woman. A critical study of the biological diagnosis of hyperandrogenism]. Heim J; Massart C Nouv Presse Med; 1982 Nov; 11(47):3495-9. PubMed ID: 6218480 [TBL] [Abstract][Full Text] [Related]
34. Treatment of hirsutism with spironolactone. Cumming DC; Yang JC; Rebar RW; Yen SS JAMA; 1982 Mar; 247(9):1295-8. PubMed ID: 7199587 [TBL] [Abstract][Full Text] [Related]
35. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women. Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314 [TBL] [Abstract][Full Text] [Related]
36. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women. Stanczyk FZ; Saxena T; Lobo RA J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067 [TBL] [Abstract][Full Text] [Related]
37. Androgens in hirsute women referred for electroepilation. Fogh H; Worm AM; Forkert B; Bennett P Acta Derm Venereol; 1989; 69(2):179-82. PubMed ID: 2564241 [TBL] [Abstract][Full Text] [Related]
38. Hirsutism: diagnostic approach and stimulation-suppression dynamics of androgens in the female. Biberoglu K; Behrman SJ Int J Fertil; 1982; 27(3):146-52. PubMed ID: 6128319 [TBL] [Abstract][Full Text] [Related]
39. The influence of androgens on insulin resistance. Shoupe D; Lobo RA Fertil Steril; 1984 Mar; 41(3):385-8. PubMed ID: 6230259 [TBL] [Abstract][Full Text] [Related]
40. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]